(Total Views: 78)
Posted On: 05/27/2025 9:15:58 AM
Post# of 852
$BCTX clears safety milestone in Bria-OTS™ Phase 1/2 study and doses first patient in CPI combo arm for metastatic breast cancer. Monotherapy patient shows complete lung metastasis resolution. Major step toward personalized cancer care. Read: https://globenewswire.com/news-release/2025/0...bitor.html
(0)
(0)
